Back to Companies
ADIAL PHARMACEUTICALS, INC.
ADILNasdaqCIK: 0001513525
ADIAL PHARMACEUTICALS, INC. (ADIL) shows 8 recent insider filings from 3 insiders, with all of them on the buy side. With $106.3K in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $106.3K). Davidson Matt (Chief Development Officer, Director) is the most active by dollar volume, and the single largest transaction was $671.7K by Davidson Matt. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$778.1K
Purchases
$106.3K
Sales
$0
Unique Insiders
3
Recent Insider Trades
8 loaded
| Jul 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP | 10% Owner | Buy | $8.7K |
| Jul 13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP | 10% Owner | Buy | $32.6K |
| Jul 1 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP | 10% Owner | Buy | $65.0K |
| Jun 29 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP | 10% Owner | Other | $0 |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Young Wendy B. | Director | Other | $36 |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | Chief Development Officer, Director | Grant | $671.7K |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | Chief Development Officer, Director | Other | $0 |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Young Wendy B. | Director | Other | $0 |
8 filings